Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Veradermics, Incorporated(MANE) | 2,401,868 | 2,401,868 | 0 | $151.68M | $295.29M | 28.42% | +$143.61M |
| Zenas BioPharma, Inc.(ZBIO) | 5,037,854 | 5,037,854 | 0 | $98.49M | $127.86M | 12.31% | +$29.37M |
| CRISPR Therapeutics AG(CRSP) | 2,038,763 | 2,038,763 | 0 | $96.98M | $111.19M | 10.70% | +$14.21M |
| Avalyn Pharma, Inc | 0 | 3,308,649 | +3,308,649 | $0 | $108.92M | 10.48% | +$108.92M |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | $69.44M | $94.44M | 9.09% | +$25.00M |
| Odyssey Therapeutics, Inc. | 0 | 3,794,883 | +3,794,883 | $0 | $71.00M | 6.83% | +$71.00M |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $43.18M | $55.15M | 5.31% | +$11.97M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,615,384 | +100,455 | $58.48M | $49.98M | 4.81% | -$8.49M |
| Mineralys Therapeutics, Inc.(MLYS) | 1,563,966 | 1,563,966 | 0 | $42.37M | $42.20M | 4.06% | -$172.0K |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | $32.22M | $32.14M | 3.09% | -$80.3K |
| Mobia Medical, Inc | 0 | 1,986,072 | +1,986,072 | $0 | $26.61M | 2.56% | +$26.61M |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | $7.03M | $9.43M | 0.91% | +$2.40M |
| Oculis Holding AG | 641,022 | 641,022 | 0 | $17.04M | $8.89M | 0.86% | -$8.15M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 137,753 | 137,753 | 0 | $2.89M | $4.60M | 0.44% | +$1.71M |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | $5.09M | $1.29M | 0.12% | -$3.80M |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 0 | -2,346,630 | $269.44M | $0 | — | -$269.44M |
| Oruka Therapeutics, Inc.(ORKA) | 430,330 | 0 | -430,330 | $21.11M | $0 | — | -$21.11M |